Investors purchased shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading hours on Tuesday. $80.58 million flowed into the stock on the tick-up and $47.64 million flowed out of the stock on the tick-down, for a money net flow of $32.94 million into the stock. Of all equities tracked, UnitedHealth Group had the 11th highest net in-flow for the day. UnitedHealth Group traded down ($0.40) for the day and closed at $136.87

UNH has been the topic of a number of research reports. Jefferies Group reiterated a “buy” rating and issued a $153.00 target price on shares of UnitedHealth Group in a report on Tuesday, May 17th. Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, May 18th. Credit Suisse Group AG restated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, May 18th. Leerink Swann restated a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Finally, Sanford C. Bernstein initiated coverage on UnitedHealth Group in a report on Wednesday, June 15th. They issued an “outperform” rating and a $171.00 price objective on the stock. One research analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $153.44.

The firm’s 50 day moving average price is $141.53 and its 200 day moving average price is $133.50. The firm has a market capitalization of $130.35 billion and a P/E ratio of 21.42.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. The business had revenue of $46.50 billion for the quarter, compared to analyst estimates of $45.05 billion. Equities research analysts predict that UnitedHealth Group Inc. will post $7.91 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Investors of record on Friday, September 9th will be issued a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date of this dividend is Tuesday, September 6th.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, June 16th. The stock was sold at an average price of $138.58, for a total transaction of $692,900.00. Following the transaction, the director now directly owns 72,229 shares of the company’s stock, valued at approximately $10,009,494.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,500 shares of the business’s stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $139.80, for a total value of $768,900.00. Following the transaction, the director now directly owns 59,019 shares in the company, valued at $8,250,856.20. The disclosure for this sale can be found here.

Other hedge funds and institutional investors have bought and sold shares of the company. Rail Splitter Capital Management LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $5,800,000. Cedar Hill Associates LLC raised its position in shares of UnitedHealth Group by 1.8% in the fourth quarter. Cedar Hill Associates LLC now owns 118,311 shares of the healthcare conglomerate’s stock worth $13,918,000 after buying an additional 2,086 shares in the last quarter. American International Group Inc. raised its position in shares of UnitedHealth Group by 0.8% in the fourth quarter. American International Group Inc. now owns 454,179 shares of the healthcare conglomerate’s stock worth $53,429,000 after buying an additional 3,479 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in shares of UnitedHealth Group by 3.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 2,825,116 shares of the healthcare conglomerate’s stock worth $332,347,000 after buying an additional 88,802 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of UnitedHealth Group by 3.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,108,013 shares of the healthcare conglomerate’s stock worth $365,706,000 after buying an additional 92,985 shares in the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.